This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

METHOXACET-C1/8 (2015-01-27)

Starting date:
January 27, 2015
Posting date:
February 2, 2015
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type III
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-43603

Recalled Products

METHOXACET-C1/8

Reason

An OOS Codeine Phosphate assay result was reported at 24 months stability testing.

Depth of distribution

Wholesalers

Affected products

METHOXACET-C1/8

DIN, NPN, DIN-HIM
DIN 02236872
Dosage form

Caplets

Strength

Methocarbamol 400 mg
Acetaminophen 325 mg
Codeine phosphate 8 mg

Lot or serial number

664758A
664758B
669629

Companies
Recalling Firm
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
Marketing Authorization Holder
Teva Canada Ltd.
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA

Date modified: